| Aug 8 |
Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results
|
| Aug 1 |
Veru to Report Fiscal 2024 Third Quarter Financial Results on August 8, 2024
|
| Jul 29 |
Veru to Participate in the BTIG Virtual Biotechnology Conference
|
| Jul 2 |
Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism
|
| Jul 2 |
Veru (NASDAQ:VERU) investors are sitting on a loss of 89% if they invested three years ago
|
| Jun 24 |
Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association's 84th Scientific Sessions
|
| Jun 18 |
Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024
|
| Jun 17 |
Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Shareholders
|
| Jun 10 |
Veru to Present at the American Diabetes Association's 84th Scientific Sessions
|
| May 29 |
Comstock And 2 Other Stocks Under $2 Insiders Are Buying
|
